News Headlines Article

Judge OKs $762 million Amgen settlement
Modern Healthcare

A federal judge accepted biotechnology giant Amgen’s guilty plea that it illegally marketed its anemia drug Aranesp, clearing the way for a $762 million settlement agreement. The Thousand Oaks, Calif.-based company has agreed to pay $762 million in criminal fines and a civil settlement, according to the U.S. Attorney’s Office in the Eastern District of New York.

“We will continue to pursue those who improperly market pharmaceuticals and biologics at the expense of individual patients’ well-being and the federal healthcare system as a whole,” Stuart Delery, principal deputy assistant attorney general for the Justice Department’s civil division, said in a news release.